相关实验视频
Updated: Jun 8, 2025
07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
84.7K
癌症中缺氧诱导的炎症细胞死亡的机制
Abhishek Bhardwaj1, Maria C Panepinto2,3, Beatrix Ueberheide2,3,4,5
1Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA. abhishek.bhardwaj@nyulangone.org.
Nature
|November 7, 2024
概括
抑制蛋白酸酶1B (PTP1B) 会触发RNF213的激活,导致缺氧乳腺癌的炎症性细胞死亡. 这一途径涉及CYLD/SPATA2降解和NLRP3炎症酶激活,提供了潜在的治疗点.
科学领域:
- 癌症学
- 分子生物学
- 免疫学
背景情况:
- 低毒性癌细胞表现出治疗耐药性并促进复发.
- 蛋白氨酸酸酶1B (PTP1B) 缺乏/ 抑制激活RNF213, 在缺氧的情况下诱导HER2阳性乳腺癌的细胞死亡.
- RNF213是一种大型蛋白质,参与莫亚莫亚病,脂毒性和天生的免疫力.
研究的目的:
- 通过 PTP1B 和 ABL1/2 阐明 RNF213 的调节机制.
- 研究PTP1B-RNF213轴在低氧瘤中调节炎性细胞死亡途径中的作用.
- 确定缺氧乳腺癌的潜在治疗点.
主要方法:
- 通过PTP1B和ABL1/2研究了RNF213酸化的相互控制.
- 评估了RNF213寡合化和RZ域激活.
- 通过 RNF213 RZ 域调解的 CYLD/SPATA2 的无处不在和降解.
- 研究了NF-κB激活和NLRP3炎症酶诱导.
- 在人类表皮生长因子受体2-阳性乳腺癌异体移植中使用CYLD和NLRP3删除模型.
- 使用RNF213突变体进行溶解研究.
主要成果:
- PTP1B和ABL1/2相互调节RNF213酸化,寡合化和RZ域的激活.
- RNF213 RZ域诱导CYLD/SPATA2降解,导致NF-κB激活和NLRP3炎症酶诱导.
- 低氧诱导的内质网膜应激结合NLRP3炎症酶激活会触发热细胞死亡.
- 在体内,CYLD删除模仿PTP1B缺陷的抗瘤作用,而NLRP3删除则被阻断.
- 通过复制研究证实了RNF213RZ域介导的瘤细胞死亡.
结论:
- 确定了一种新的PTP1B-RNF213-CYLD-SPATA2通路,对于控制缺氧瘤的炎症细胞死亡至关重要.
- 提供了关于RNF213调节及其在癌症中的作用的新见解.
- 突出了针对低氧乳腺癌这一途径的潜在治疗含义.
- 可能与莫亚莫亚病,炎症和自身免疫性疾病有关.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:17The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:23Hypoxia
943
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
943